Structural and Functional Characterization of an Agonistic Anti-human EphA2 Monoclonal Antibody
Overview
Molecular Biology
Affiliations
We report here the three-dimensional structure of human ephrin type A receptor 2 (EphA2) bound to the Fab (fragment antigen binding) of an agonistic human antibody (1C1; IgG1/κ). The structure of the corresponding complex was solved at a resolution of 2.5 Å using molecular replacement and constitutes the first reported structure of a human ephrin receptor bound to an antibody. We have also defined the corresponding functional epitope using a mutagenesis-based approach. This study revealed discrete structural features that determine the fine specificity of 1C1 to EphA2. Our data also provided a molecular basis for 1C1 mechanism of action. More precisely, we propose that its agonistic, internalizing properties are the result of ligand mimicry by the third heavy-chain complementarity-determining region of 1C1. Because EphA2 is an important contributor to cancer formation and progression, these findings may have implications for designing the next generation of anti-tumor therapies.
Sampson J, Cannon D, Duan J, Epstein J, Sergeeva A, Katsamba P J Mol Biol. 2024; 436(16):168640.
PMID: 38844044 PMC: 11339910. DOI: 10.1016/j.jmb.2024.168640.
Sampson J, Cannon D, Duan J, Epstein J, Sergeeva A, Katsamba P bioRxiv. 2024; .
PMID: 38712280 PMC: 11071377. DOI: 10.1101/2024.04.22.590325.
Advances in antibody discovery from human BCR repertoires.
Xu Z, Ismanto H, Zhou H, Saputri D, Sugihara F, Standley D Front Bioinform. 2022; 2:1044975.
PMID: 36338807 PMC: 9631452. DOI: 10.3389/fbinf.2022.1044975.
Antibody-mediated depletion of programmed death 1-positive (PD-1) cells.
Zhai Y, Dong S, Li H, Zhang Y, Shami P, Chen M J Control Release. 2022; 349:425-433.
PMID: 35820540 PMC: 10699550. DOI: 10.1016/j.jconrel.2022.07.010.
Contrastive learning on protein embeddings enlightens midnight zone.
Heinzinger M, Littmann M, Sillitoe I, Bordin N, Orengo C, Rost B NAR Genom Bioinform. 2022; 4(2):lqac043.
PMID: 35702380 PMC: 9188115. DOI: 10.1093/nargab/lqac043.